Kaleido Biosciences Inc.

01/21/2022 | Press release | Distributed by Public on 01/21/2022 10:10

Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress